About SM Labs
SM Labs is a Healthcare company based in Hyderabad (India). Manufacturing of drug intermediates and pharmaceutical chemicals in India. It operates in the Healthcare and Chemicals & Materials sectors. The company has 36 employees. Its Indian entity Sm Labs Private Limited reported revenue of ₹6.16 Cr. SM Labs offers products and services including 5-Cyanophthalide and 5-Bromophthalide. Its focus areas include Healthcare and Pharmaceuticals, Pharmaceuticals, Drug Manufacturing and Intermediates Production.
Company details
SM Labs is known for its production of drug intermediates like 5-Cyanophthalide, 5-Bromophthalide, Quinolinic acid, and Piperazine Anhydrous, along with active pharmaceutical ingredients and intermediates. State-of-the-art infrastructure is utilized by the company for bulk drug manufacturing, supported by advanced reaction capabilities and a focus on research and development. Customer service is enhanced through specialized staff training, while ethical practices are maintained in operations based in Hyderabad, India. International market expansion is pursued via web-enabled interfaces. (72 words)
- Headquarters Hyderabad, India
- Employees 36
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Legal Name Sm Labs Private Limited
- Date of Incorporation 19 Apr, 2000
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹6.16 Cr
FY 2024 · -23% YoY
- Net Loss-₹2.17 Cr
FY 2024 · -35% margin
- EBITDA-₹1.73 Cr
FY 2024 · -28% margin
- Employee Count36
Associated legal entities of SM Labs
SM Labs operates through Sm Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sm Labs Private Limited CIN U52399TG2000PTC034286 | Active | 19 Apr 2000 | Hyderabad, Telangana | ₹6.2 Cr | 36 | 5 | View details |
Products & Services of SM Labs
SM Labs offers a comprehensive portfolio of products and services, including 5-Cyanophthalide and 5-Bromophthalide.
This intermediate is produced for use in pharmaceutical manufacturing processes
This chemical is manufactured as an intermediate for pharmaceutical applications
Board of directors of Sm Labs Private Limited (SM Labs)
Sm Labs Private Limited is the primary company behind SM Labs. The board of Sm Labs Private Limited currently have 5 directors; the longest-serving is Maheswari Gudooru, appointed in 2000. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Maheswari Gudooru DIN 01045067 | Director | 19 Apr 2000 | 26 yrs 6 mo | Sm Labs Private Limited |
| Malla Reddy Madireddy DIN 01044873 | Managing Director | 19 Apr 2000 | 26 yrs 6 mo | Sm Labs Private Limited |
| Manikya Reddy Gudoori DIN 01044926 | Director | 19 Apr 2000 | 26 yrs 6 mo | Sm Labs Private Limited |
| Madhukar Vempalla DIN 03193474 | Director | 22 Nov 2010 | 15 yrs 11 mo | Sm Labs Private Limited |
| Krupaker Reddy Chilukuri DIN 03273618 | Director | 22 Nov 2010 | 15 yrs 11 mo | Sm Labs Private Limited |
Financials of SM Labs
Figures of Sm Labs Private Limited, the primary company behind SM Labs, for FY 2024. Revenue was ₹6.16 Cr (-23% year on year). Net loss was -₹2.17 Cr (-35% margin). EBITDA was -₹1.73 Cr (-28% margin). Revenue has grown at a compounded annual rate of -42% over three years and -1% over five years.
- ₹6.16 CrRevenue · FY 2024 · -23% YoY
- -₹2.17 CrNet loss · -35% margin
- -₹1.73 CrEBITDA · -28% margin
- ₹5 LakhPaid-up capital
- 36Employees (provident fund records)
- -42%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sm Labs Private Limited are on its company page.
Detailed financial statements for SM Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SM Labs
SM Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
SM Labs has 36 employees.
The primary company behind SM Labs, Sm Labs Private Limited, reported revenue of ₹6.16 Cr for FY 2024, down 23% year on year.
SM Labs is known for its production of drug intermediates like 5-Cyanophthalide, 5-Bromophthalide, Quinolinic acid, and Piperazine Anhydrous, along with active pharmaceutical ingredients and intermediates. State-of-the-art infrastructure is utilized by the company for bulk drug manufacturing, supported by advanced reaction capabilities and a focus on research and development. Customer service is enhanced through specialized staff training, while ethical practices are maintained in operations based in Hyderabad, India. International market expansion is pursued via web-enabled interfaces. (72 words).
SM Labs offers 5-Cyanophthalide and 5-Bromophthalide.
SM Labs operates through Sm Labs Private Limited.
The legal entities of SM Labs currently have 5 directors, including Madhukar Vempalla, Krupaker Reddy Chilukuri, Maheswari Gudooru and others.